Drug Trials: Challenges for Alzheimer’s and Other Urgent Needs

source: Harvard University     2016年4月18日
This Forum explored the challenges and complexities of drug trials, and how they impact disease treatment and prevention — particularly for conditions that currently have little or no therapeutic options. As a case study, the panel discussed Alzheimer’s and several drugs in development for that disease, but also addressed broader concerns related to the pharmaceutical testing pipeline for unmet medical needs as a whole. This event was presented April 15, 2016 in partnership with HHMI Tangled Bank Studios, in collaboration with STAT, and in association with NOVA.
Watch the entire series from The Forum at Harvard T.H. Chan School of Public Health at www.ForumHSPH.org.